STEWARD ST. ELIZABETHS MEDICAL CTR — History
CCN 220036 | 3-year financial timeline | COVID resilience: 71/100
🛡️ Public data only — no PHI permitted on this instance.
$429M
Latest Revenue (FY2022)
+6.2%
Revenue CAGR (3yr)
0.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $380M | $422M | $429M | +1.4% | +6.2% |
| Operating Expenses | $391M | $395M | $426M | +7.7% | +4.3% |
| Operating Margin | -2.9% | 6.5% | 0.7% | -89.4% | +0.0% |
| Net Income | $-11M | $27M | $3M | -89.3% | +0.0% |
| Licensed Beds | 220 | 240 | 244 | +1.7% | +5.3% |
| Total Patient Days | 54,890 | 58,059 | 61,464 | +5.9% | +5.8% |
| Medicare Day % | 35% | 33% | 32% | -5.1% | -4.8% |
| Medicaid Day % | 17% | 17% | 15% | -16.2% | -6.8% |
COVID Impact & Recovery
Resilience Score: 71/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +12.8% ($380M → $429M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.2%
This Hospital
+7.6%
State Avg
Latest Margin
0.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $453M | 2.5% |
| FY2024 (proj) | $477M | 4.3% |
| FY2025 (proj) | $501M | 6.1% |